These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
640 related items for PubMed ID: 22172603
1. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Linn M, Collnot EM, Djuric D, Hempel K, Fabian E, Kolter K, Lehr CM. Eur J Pharm Sci; 2012 Feb 14; 45(3):336-43. PubMed ID: 22172603 [Abstract] [Full Text] [Related]
2. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Zhang K, Yu H, Luo Q, Yang S, Lin X, Zhang Y, Tian B, Tang X. Eur J Pharm Biopharm; 2013 Nov 14; 85(3 Pt B):1285-92. PubMed ID: 23562534 [Abstract] [Full Text] [Related]
3. PVP and surfactant combined carrier as an effective absorption enhancer of poorly soluble astilbin in vitro and in vivo. He Y, Liu H, Xie Z, Liao Q, Lai X, Du Z. Drug Dev Ind Pharm; 2014 Feb 14; 40(2):237-43. PubMed ID: 23350723 [Abstract] [Full Text] [Related]
4. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Fei Y, Kostewicz ES, Sheu MT, Dressman JB. Eur J Pharm Biopharm; 2013 Nov 14; 85(3 Pt B):1274-84. PubMed ID: 23500116 [Abstract] [Full Text] [Related]
5. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability. Yang H, Teng F, Wang P, Tian B, Lin X, Hu X, Zhang L, Zhang K, Zhang Y, Tang X. Int J Pharm; 2014 Dec 30; 477(1-2):88-95. PubMed ID: 25455766 [Abstract] [Full Text] [Related]
6. Supersaturated polymeric micelles for oral cyclosporine A delivery. Yu H, Xia D, Zhu Q, Zhu C, Chen D, Gan Y. Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):1325-36. PubMed ID: 23954511 [Abstract] [Full Text] [Related]
7. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole. Taupitz T, Dressman JB, Buchanan CM, Klein S. Eur J Pharm Biopharm; 2013 Apr 30; 83(3):378-87. PubMed ID: 23201048 [Abstract] [Full Text] [Related]
8. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments. O'Shea JP, Faisal W, Ruane-O'Hora T, Devine KJ, Kostewicz ES, O'Driscoll CM, Griffin BT. Eur J Pharm Biopharm; 2015 Oct 30; 96():207-16. PubMed ID: 26215636 [Abstract] [Full Text] [Related]
9. Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement. Quan G, Niu B, Singh V, Zhou Y, Wu CY, Pan X, Wu C. Int J Nanomedicine; 2017 Oct 30; 12():8801-8811. PubMed ID: 29263669 [Abstract] [Full Text] [Related]
10. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. Thiry J, Kok MG, Collard L, Frère A, Krier F, Fillet M, Evrard B. Eur J Pharm Sci; 2017 Mar 01; 99():1-8. PubMed ID: 27951411 [Abstract] [Full Text] [Related]
11. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Prabhu S, Ortega M, Ma C. Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087 [Abstract] [Full Text] [Related]
12. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. Jia Z, Lin P, Xiang Y, Wang X, Wang J, Zhang X, Zhang Q. Eur J Pharm Biopharm; 2011 Sep 14; 79(1):126-34. PubMed ID: 21658449 [Abstract] [Full Text] [Related]
13. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption. Guan J, Jin L, Liu Q, Xu H, Wu H, Zhang X, Mao S. Eur J Pharm Sci; 2019 Nov 01; 139():105043. PubMed ID: 31415903 [Abstract] [Full Text] [Related]
14. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Ingels F, Beck B, Oth M, Augustijns P. Int J Pharm; 2004 Apr 15; 274(1-2):221-32. PubMed ID: 15072798 [Abstract] [Full Text] [Related]
15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C. Eur J Pharm Sci; 2013 Jul 16; 49(4):679-98. PubMed ID: 23727464 [Abstract] [Full Text] [Related]
16. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Hughey JR, Keen JM, Miller DA, Kolter K, Langley N, McGinity JW. Eur J Pharm Sci; 2013 Mar 12; 48(4-5):758-66. PubMed ID: 23348153 [Abstract] [Full Text] [Related]
17. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. Zi P, Zhang C, Ju C, Su Z, Bao Y, Gao J, Sun J, Lu J, Zhang C. Eur J Pharm Sci; 2019 Jun 15; 134():233-245. PubMed ID: 31028820 [Abstract] [Full Text] [Related]
18. Design of fenofibrate microemulsion for improved bioavailability. Hu L, Wu H, Niu F, Yan C, Yang X, Jia Y. Int J Pharm; 2011 Nov 28; 420(2):251-5. PubMed ID: 21907776 [Abstract] [Full Text] [Related]
19. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus. Altamimi MA, Neau SH. Drug Dev Ind Pharm; 2016 Mar 28; 42(3):446-455. PubMed ID: 26266965 [Abstract] [Full Text] [Related]
20. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium. Borkar N, Xia D, Holm R, Gan Y, Müllertz A, Yang M, Mu H. Eur J Pharm Sci; 2014 Jan 23; 51():204-10. PubMed ID: 24134899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]